enGene TherapeuticsENGN
那斯達克 · USD
1.96
+0.04
(+2.08%)
收盤 09/26 03:59 (UTC+8)
09/26 03:59 (UTC+8)
enGene TherapeuticsENGN
1.96
+0.04
(+2.08%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 34,014 | 31,968 | 31,185 | 39,481 | 29,947 | 27,124 | - | 17,455 | 16,759 | 17,310 |
研發費用 | 20,090 | 22,195 | 22,255 | 31,722 | 22,575 | 20,209 | 19,974 | 11,273 | 11,549 | 9,855 |
推銷及管理費用 | 13,924 | 9,773 | 8,930 | 7,759 | 7,372 | 6,915 | 6,639 | 6,182 | 4,682 | 6,087 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | 528 | 1,368 |
營業利益 | -34,014 | -31,968 | -31,185 | -39,481 | -29,947 | -27,124 | -26,613 | -17,455 | -16,759 | -17,310 |
其他收入及費用 | 2,356 | 2,486 | 2,165 | 1,854 | 1,953 | 2,283 | 2,767 | 2,931 | - | - |
利息費用 | 843 | 745 | 732 | 750 | 758 | 734 | 752 | 756 | 751 | 728 |
稅前純益 | -32,501 | -30,227 | -29,752 | -38,377 | -28,752 | -25,575 | -24,598 | -15,280 | -14,177 | -14,963 |
所得稅 | - | - | - | -497 | 239 | 240 | 18 | 19 | -29 | 21 |
稅後純益 | -32,501 | -30,227 | -29,752 | -37,880 | -28,991 | -25,815 | -24,616 | -15,299 | -14,148 | -14,984 |
基本每股稅後盈餘(元) | -0.47 | -0.43 | -0.44 | 3.85 | -0.57 | -0.51 | -0.48 | 2.62 | -0.32 | -0.38 |
稀釋每股稅後盈餘(元) | -0.46 | -0.44 | -0.44 | 3.85 | -0.57 | -0.51 | -0.48 | 2.58 | -0.32 | -0.38 |
基本平均股數(千股) | 69734.00 | 69724.00 | 67263.00 | 51385.00 | 51097.00 | 51019.00 | 50976.00 | 44321.00 | 44168.00 | 39443.00 |
稀釋平均股數(千股) | 69734.00 | 69724.00 | 67263.00 | 51385.00 | 51097.00 | 51019.00 | 50976.00 | 44321.00 | 44168.00 | 39443.00 |
還原基本每股稅後盈餘(元) | -0.47 | -0.43 | -0.44 | 3.85 | -0.57 | -0.51 | -0.48 | 2.62 | -0.32 | -0.38 |
還原稀釋每股稅後盈餘(元) | -0.46 | -0.44 | -0.44 | 3.85 | -0.57 | -0.51 | -0.48 | 2.58 | -0.32 | -0.38 |
還原基本平均股數(千股) | 69,734 | 69,724 | 67,263 | 51,385 | 51,097 | 51,019 | 50,976 | 44,321 | 44,168 | 39,443 |
還原稀釋平均股數(千股) | 69,734 | 69,724 | 67,263 | 51,385 | 51,097 | 51,019 | 50,976 | 44,321 | 44,168 | 39,443 |
EBITDA(千元) | -31,760 | -29,796 | -29,422 | -37,878 | -28,532 | -25,930 | -24,526 | -14,673 | -13,344 | -14,157 |